欢迎访问BMJ临床实践/BMJ Best Practice

Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-382.

摘要

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-382.

摘要

2. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Recomm Rep. 2006;55:1-33.

3. Cortese MM, Baughman AL, Brown K, et al. A "new age" in pertussis prevention new opportunities through adult vaccination. Am J Prev Med. 2007;32:177-185.

摘要

4. Public Health England. Guidelines for the public health management of pertussis in England. December 2016. http://www.gov.uk (last accessed 14 March 2017).

全文

5. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010;330:982-985.

摘要

6. Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics. 2011;3:183-188.

摘要

7. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect. 2014;142:672-684.

摘要

8. Cherry JD. Epidemic pertussis in 2012: the resurgence of a vaccine-preventable disease. N Engl J Med. 2012;367:785-787.

9. Lavine J, Broutin H, Harvill ET, et al. Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine. 2010;29:11-16.

10. McGirr A, Fisman DN. Duration of pertussis immunity after DTaP immunization: a meta-analysis. Pediatrics. 2015;135:331-343.

11. World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:385-400.

12. Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics. 2005;115:1422-1427.

摘要

13. Tan T, Trindade E, Skowronsk D. Epidemiology of pertussis. Pediatr Infect Dis J. 2005;24:S10-S18.

摘要

14. Health Protection Agency. Confirmed pertussis cases in England and Wales: update to end-April 2012. June 2012. http://www.hpa.org.uk (last accessed 14 March 2017).

全文

15. Galanis E, King AS, Varughese P, et al. Changing epidemiology and emerging risk groups for pertussis. CMAJ. 2006;174:451-452.

摘要

16. Cherry JD, Grimprel E, Guiso N, et al. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24:S25-S34.

摘要

17. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005;24:S104-S108.

摘要

18. Cherry JD. Epidemiology of pertussis. Pediatr Infect Dis J. 2006;25:361-362.

摘要

19. Cherry JD. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis. 1999;28:S112-S117.

摘要

20. Bamberger ES, Srugo I. What is new in pertussis? Eur J Pediatr. 2008;167:133-139.

摘要

21. Centers for Disease Control and Prevention. 2012 final pertussis surveillance report. August 2013. http://www.cdc.gov (last accessed 14 March 2017).

全文

22. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2012;61:468-470.

23. Centers for Disease Control and Prevention. Pertussis. In: Atkinson W, Wolfe S, Hamborsky J, eds. Epidemiology and prevention of vaccine-preventable diseases. 12th ed. Washington DC: Public Health Foundation; 2012.

全文

24. Wang K, Bettiol S, Thompson MJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane Database Syst Rev. 2014;(9):CD003257.

25. Skoff TH, Kenyon C, Cocoros N, et al. Sources of infant pertussis infection in the United States. Pediatrics. 2015;136:635-641.

26. Clark TA, Messonnier NE, Hadler SC. Pertussis control: time for something new? Trends Microbiol. 2012;20:211-213.

摘要

27. Wendelboe AM, Njamkepo E, Bourillon A, et al. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293-299.

摘要

28. Hallander HO, Gnarpe J, Gnarpe H, et al. Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children. Scand J Infect Dis. 1999;31:281-286.

摘要

29. Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician. 2006;74:420-426.

摘要

30. De Serres G, Shadmani R, Duval B, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis. 2000;182:174-179.

摘要

31. Elahi S, Buchanan RM, Babiuk LA, et al. Maternal immunity provides protection against pertussis in newborn piglets. Infect Immun. 2006;74:2619-2627.

32. Centers for Disease Control and Prevention; Healthcare Infection Control Practices Advisory Committee (HICPAC). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. 2007. http://www.cdc.gov/ (last accessed 14 March 2017).

全文

33. Centers for Disease Control and Prevention. Pertussis (whooping cough): information for clinicians. July 2014. http://www.cdc.gov (last accessed 14 March 2017).

全文

34. Zhang L, Prietsch SO, Axelsson I, et al. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev. 2014;(9):CD001478.

35. Robinson CL, Romero JR, Kempe A, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:134-135.

36. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women: Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013;62:131-135.

37. Kim DK, Riley LE, Harriman KH, et al. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2017. MMWR Morb Mortal Wkly Rep. 2017;66:136-138.

38. Committee on Obstetric Practice. ACOG committee opinion no. 521: update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol. 2012;119:690-691.

摘要

39. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52:157-162.

40. Pichichero ME, Casey JR, Almudevar A. Nonprotective responses to pediatric vaccines occur in children who are otitis prone. Pediatr Infect Dis J. 2013;32:1163-1168.

摘要

41. Cornia PB, Hersh AL, Lipsky BA, et al. Does this coughing adolescent or adult patient have pertussis? JAMA. 2010;304:890-896.

摘要

42. Tozzi AE, Rava L, Ciofi degli Atti ML, et al, the Progetto Pertosse Working Group. Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics. 2003;112:1069-1075.

摘要

43. Centers for Disease Control and Prevention. Pertussis (whooping cough): treatment. September 2015. http://www.cdc.gov (last accessed 14 March 2017).

全文

44. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. Chapter 10: pertussis. 2015. http://www.cdc.gov (last accessed 14 March 2017).

全文

45. World Health Organization. WHO-recommended surveillance standard of pertussis. http://www.who.int (last accessed 14 March 2017).

全文

46. Palmer CM, McCall B, Jarvinen K, et al. Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age. Commun Dis Intell. 2007;31:202-205.

摘要

47. Loeffelholz MJ, Thompson CJ, Long KS, et al. Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis. J Clin Microbiol. 1999;37:2872-2876.

48. Heininger U, Schmidt-Schlapfer G, Cherry JD, et al. Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics. 2000;105:E31.

摘要

49. Doern GV. Detection of selected fastidious bacteria. Clin Infect Dis. 2000;30:166-173.

50. Litt DJ, Samuel D, Duncan J, et al. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J Med Microbiol. 2006;55:1223-1228.

摘要

51. Miyashita N, Akaike H, Teranishi H, et al. Diagnostic value of symptoms and laboratory data for pertussis in adolescent and adult patients. BMC Infect Dis. 2013;13:129.

52. Dragsted DM, Dohn B, Madsen J, et al. Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol. 2004;53:749-754.

摘要

53. Murray EL, Nieves D, Bradley JS, et al. Characteristics of severe bordetella pertussis infection among infants ≤90 days of age admitted to pediatric intensive care units – southern California, September 2009–June 2011. J Ped Infect Dis. 2013;2:1-6.

54. Raguckas SE, VandenBussche HL, Jacobs C, et al. Pertussis resurgence: diagnosis, treatment, prevention, and beyond. Pharmacotherapy. 2007;27:41-52.

摘要

55. Brown MO, St. Anna L, Ohl M. Clinical inquiries. What are the indications for evaluating a patient with cough for pertussis? J Fam Pract. 2005;54:74-76.

摘要

56. Alvarez-Elcoro S, Enzler MJ. The macrolides: erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc. 1999;74:613-634.

摘要

57. Halperin SA, Bortolussi R, Langley JM, et al. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive Bordetella pertussis infection. Pediatrics. 1999;104:E42.